Craig C. Hopkinson, EVP R&D, Chief Medical Officer at Alkermes plc. (ALKS), sold 23,966 shares at $24.76 ($593K) on 2022-02-23, disclosed to the SEC on 2022-02-24.
Seasonal sale ($593k) by EVP R&D, Chief Medical Officer — this insider has traded ALKS in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.76 | 11,983 | $297K | 50.0% |
| 2 | $24.76 | 11,983 | $297K | 50.0% |
| Total | $24.76 avg | 23,966 | $593K | 100% |
| Filing → |
| ALKS | SELL | 2026-07-01 | $464K | — | Filing → |
| ALKS | SELL | 2026-06-01 | $375K | — | Filing → |
| ALKS | SELL | 2026-05-01 | $301K | — | Filing → |